Ultralife Corp. (ULBI) Tops Q4 EPS by 21c

Ultralife Corp. (NASDAQ: ULBI) reported Q4 EPS of $0.45, $0.21 better than the analyst estimate of $0.24. Revenue for the quarter came in at $48.5 million versus the consensus estimate of $57 million.

For earnings history and earnings-related data on Ultralife Corp. (ULBI) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Roots Corporation to go private in C$4.10-per-share deal with Marquee Brands
• Holcim to acquire Fermacell from James Hardie for EUR 840M